CSS LLC’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

CSS LLC’s Portfolio SGTX Stock Details SGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14	Closed	-$315	–	1070
2023 Q2	$315	Buy	+14	New	+$102	﹤0.01%	891

Other funds holding SGTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CSS LLC's SGTX Position: Q3 2023 in Review

CSS LLC sold out of Sigilon Therapeutics, Inc. Common Stock (SGTX) in Q3 2023, closing a stake of 13,292 shares — an estimated $299K sold.

CSS LLC first reported a position in SGTX in Q2 2023 and held it in 1 quarter. The position peaked at $299K in Q2 2023. 1 fund tracked by Wall St. Rank holds SGTX as of Q3 2023.

CSS LLC reported no remaining Sigilon Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
CSS LLC sold 13,292 Sigilon Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $299K.
CSS LLC first reported a position in Sigilon Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
CSS LLC's Sigilon Therapeutics, Inc. Common Stock position peaked at $299K in Q2 2023.
1 fund tracked by Wall St. Rank held Sigilon Therapeutics, Inc. Common Stock as of Q3 2023.

Based on CSS LLC's 13F filing for Q3 2023, filed 14 Nov 2023.